A Conditionally Releasable “Do not Eat Me” CD47 Signal Facilitates Microglia‐Targeted Drug Delivery for the Treatment of Alzheimer's Disease
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Conditionally Releasable “Do not Eat Me” CD47 Signal Facilitates Microglia‐Targeted Drug Delivery for the Treatment of Alzheimer's Disease
Authors
Keywords
-
Journal
ADVANCED FUNCTIONAL MATERIALS
Volume -, Issue -, Pages 1910691
Publisher
Wiley
Online
2020-04-29
DOI
10.1002/adfm.201910691
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CD22 blockade restores homeostatic microglial phagocytosis in ageing brains
- (2019) John V. Pluvinage et al. NATURE
- SIRPα deficiency accelerates the pathologic process in models of Parkinson disease
- (2019) Jin Wang et al. GLIA
- NLRP3 inflammasome activation drives tau pathology
- (2019) Christina Ising et al. NATURE
- Crossing the blood-brain-barrier with nanoligand drug carriers self-assembled from a phage display peptide
- (2019) Lin-Ping Wu et al. Nature Communications
- Delivery across the blood-brain barrier: nanomedicine for glioblastoma multiforme
- (2019) Lynn Jena et al. Drug Delivery and Translational Research
- Microglia: Key players in neurodevelopment and neuronal plasticity
- (2018) Luba Sominsky et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Microglia in Alzheimer’s disease
- (2017) Heela Sarlus et al. JOURNAL OF CLINICAL INVESTIGATION
- Microglia-derived ASC specks cross-seed amyloid-β in Alzheimer’s disease
- (2017) Carmen Venegas et al. NATURE
- RIPK1 mediates a disease-associated microglial response in Alzheimer’s disease
- (2017) Dimitry Ofengeim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Blood–brain barrier shuttle peptides: an emerging paradigm for brain delivery
- (2016) Benjamí Oller-Salvia et al. CHEMICAL SOCIETY REVIEWS
- Targeting microglia for the treatment of Alzheimer's Disease
- (2016) Paul D. Wes et al. GLIA
- New targets for drug delivery across the BBB
- (2016) Katie Kingwell NATURE REVIEWS DRUG DISCOVERY
- From blood–brain barrier to blood–brain interface: new opportunities for CNS drug delivery
- (2016) William A. Banks NATURE REVIEWS DRUG DISCOVERY
- Untangling the brain’s neuroinflammatory and neurodegenerative transcriptional responses
- (2016) Karpagam Srinivasan et al. Nature Communications
- CD47 on artificial structures
- (2015) Christian Schütz Aging-US
- Reactive Gliosis and the Multicellular Response to CNS Damage and Disease
- (2014) Joshua E. Burda et al. NEURON
- Minimal "Self" Peptides That Inhibit Phagocytic Clearance and Enhance Delivery of Nanoparticles
- (2013) P. L. Rodriguez et al. SCIENCE
- Cystatins in Immune System
- (2013) Špela Magister et al. Journal of Cancer
- Receptor-Mediated Delivery of Magnetic Nanoparticles across the Blood–Brain Barrier
- (2012) Ruirui Qiao et al. ACS Nano
- Self inhibition of phagocytosis: The affinity of ‘marker of self’ CD47 for SIRPα dictates potency of inhibition but only at low expression levels
- (2010) Richard K. Tsai et al. BLOOD CELLS MOLECULES AND DISEASES
- Systemic combinatorial peptide selection yields a non-canonical iron-mimicry mechanism for targeting tumors in a mouse model of human glioblastoma
- (2010) Fernanda I. Staquicini et al. JOURNAL OF CLINICAL INVESTIGATION
- Cystatin F is a cathepsin C-directed protease inhibitor regulated by proteolysis
- (2008) Garth Hamilton et al. EMBO JOURNAL
- Inhibition of “self” engulfment through deactivation of myosin-II at the phagocytic synapse between human cells
- (2008) Richard K. Tsai et al. JOURNAL OF CELL BIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started